 
                Lv0
0 积分 2023-08-16 加入
 [Chinese clinical practice guideline for acute kidney injury]
                                            13小时前
                                            已完结
[Chinese clinical practice guideline for acute kidney injury]
                                            13小时前
                                            已完结
                                         [Guideline on clinical practice of molecular testing in ovarian carcinoma]
                                            10天前
                                            已完结
[Guideline on clinical practice of molecular testing in ovarian carcinoma]
                                            10天前
                                            已完结
                                         Nasopharyngeal carcinoma
                                            10天前
                                            已完结
Nasopharyngeal carcinoma
                                            10天前
                                            已完结
                                         Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance
                                            18天前
                                            已完结
Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance
                                            18天前
                                            已完结
                                         Head and Neck Cancer
                                            18天前
                                            已完结
Head and Neck Cancer
                                            18天前
                                            已完结
                                         Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition
                                            23天前
                                            已完结
Definition of locally recurrent head and neck squamous cell carcinoma: a systematic review and proposal for the Odense–Birmingham definition
                                            23天前
                                            已完结
                                         Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
                                            26天前
                                            已完结
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
                                            26天前
                                            已完结
                                         Head and Neck Cancer
                                            27天前
                                            已完结
Head and Neck Cancer
                                            27天前
                                            已完结
                                         Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
                                            1个月前
                                            已完结
Finotonlimab with chemotherapy in recurrent or metastatic head and neck cancer: a randomized phase 3 trial
                                            1个月前
                                            已完结
                                         Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
                                            1个月前
                                            已完结
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
                                            1个月前
                                            已完结